CD4 and COVID-19: In addition, nearly all COVID‐19 patients presented lymphopenia, which manifested as decreased numbers of T lymphocytes in vivo, particularly CD4+ and CD8+ T cells, and resulted in further reduction in IFN‐γ production [57].